To investigate the role of conventional radiotherapy (RT) and stereotactic body radiotherapy (SBRT) in patients with epidermal growth factor (EGFR)-mutant or anaplastic lymphoma kinase (ALK) rearrangement-positive metastatic non-small cell lung cancer (NSCLC).
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience
Borghetti, Paolo;Bonù, Marco Lorenzo;Roca, Elisa;Pedretti, Sara;Salah El Din Tantawy, Emiliano;BAIGUINI, ANNA;Greco, Diana;Triggiani, Luca;Maddalo, Marta;Alongi, Filippo;Magrini, Stefano Maria;Buglione, Michela
2018-01-01
Abstract
To investigate the role of conventional radiotherapy (RT) and stereotactic body radiotherapy (SBRT) in patients with epidermal growth factor (EGFR)-mutant or anaplastic lymphoma kinase (ALK) rearrangement-positive metastatic non-small cell lung cancer (NSCLC).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
